Moody Aldrich Partners’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-62,245
| Closed | -$1.62M | – | 189 |
|
|
2020
Q4 | $1.62M | Sell |
62,245
-38,854
| -38% | -$1.01M | 0.26% | 97 |
|
|
2020
Q3 | $3.76M | Sell |
101,099
-2
| -0% | -$74 | 0.79% | 58 |
|
|
2020
Q2 | $5.19M | Buy |
101,101
+12,341
| +14% | +$633K | 1.1% | 35 |
|
|
2020
Q1 | $2.8M | Sell |
88,760
-35,471
| -29% | -$1.12M | 0.84% | 48 |
|
|
2019
Q4 | $7.41M | Buy |
+124,231
| New | +$7.41M | 1.52% | 12 |
|
|
2018
Q2 | – | Sell |
-22,478
| Closed | -$1.63M | – | 101 |
|
|
2018
Q1 | $1.63M | Buy |
22,478
+11,151
| +98% | +$807K | 1.04% | 51 |
|
|
2017
Q4 | $746K | Buy |
11,327
+2,347
| +26% | +$155K | 0.6% | 76 |
|
|
2017
Q3 | $450K | Sell |
8,980
-2,355
| -21% | -$118K | 0.46% | 81 |
|
|
2017
Q2 | $525K | Buy |
+11,335
| New | +$525K | 0.65% | 73 |
|